Patents by Inventor Xavier Jeunemaitre

Xavier Jeunemaitre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CELIPROLOL FOR TREATING VASCULAR EHLERS-DANLOS SYNDROME IN WOMEN DURING PREGNANCY AND PERIPARTUM PERIOD
    Publication number: 20210137859
    Abstract: The present disclosure relates to the use of celiprolol or a pharmaceutically acceptable salt thereof for treating vascular Ehlers-Danlos syndrome in women during pregnancy and peripartum period.
    Type: Application
    Filed: May 20, 2020
    Publication date: May 13, 2021
    Inventors: Michael Frank, Xavier Jeunemaitre, Alexandra Benachi
  • USE OF CELIPROLOL FOR TREATING VASCULAR EHLERS-DANLOS SYNDROME IN WOMEN DURING PREGNANCY AND PERIPARTUM PERIOD
    Publication number: 20190192456
    Abstract: The present disclosure relates to the use of celiprolol or a pharmaceutically acceptable salt thereof for treating vascular Ehlers-Danlos syndrome in women during pregnancy and peripartum period.
    Type: Application
    Filed: November 8, 2018
    Publication date: June 27, 2019
    Inventors: Michael Frank, Xavier Jeunemaitre, Alexandra Benachi
  • Method to determine predisposition to hypertension
    Patent number: 6165727
    Abstract: The association of the molecular variant G-6A of the angiotensinogen gene with human hypertension is disclosed. The determination of this association enables the screening of persons to identify those who have a predisposition to high blood presure.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: December 26, 2000
    Assignees: University of Utah Research Foundation, Inserm
    Inventors: Jean-Marc Lalouel, Xavier Jeunemaitre, Richard P. Lifton, Florent Soubrier, Youri Kotelevtsev, Pierre Corvol
  • Method to determine predisposition to hypertension
    Patent number: 6153386
    Abstract: The association of the molecular variant A-20C of the angiotensinogen gene with the prognosis of human hypertension as determined by the G-6A molecular variant is disclosed. The determination of this association enables the screening of persons to identify the severity of hypertension or the severity of the risk of a predisposition to high blood pressure.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: November 28, 2000
    Assignee: University of Utah Research Foundation
    Inventors: Jean-Marc Lalouel, Xavier Jeunemaitre
  • Method to determine predisposition to hypertension
    Patent number: 5998145
    Abstract: The association of the molecular variant G-6A of the angiotensinogen gene with human hypertension is disclosed. The determination of this association enables the screening of persons to identify those who have a predisposition to high blood pressure.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: December 7, 1999
    Assignees: Univ. of Utah Research Foundation, INSERM
    Inventors: Jean-Marc Lalouel, Xavier Jeunemaitre, Richard P. Lifton, Florent Soubrier, Youri Kotelevtsev, Pierre Corvol
  • Method to determine predisposition to hypertension
    Patent number: 5763168
    Abstract: The association of the molecular variant G-6A of the angiotensinogen gene with human hypertension is disclosed. The determination of this association enables the screening of persons to identify those who have a predisposition to high blood presure.
    Type: Grant
    Filed: October 7, 1994
    Date of Patent: June 9, 1998
    Assignees: University of Utah Research Foundation, INSERM
    Inventors: Jean-Marc Lalouel, Xavier Jeunemaitre, Richard P. Lifton, Florent Soubrier, Youri Kotelevtsev, Pierre Corvol
  • Angiotensinogen gene variants and predisposition to hypertension
    Patent number: 5589584
    Abstract: The association of molecular variants of the angiotensinogen gene with human essential hypertension is disclosed. The determination of this association enables the screening of persons to identify those who have a predisposition to high blood presure.
    Type: Grant
    Filed: July 1, 1994
    Date of Patent: December 31, 1996
    Assignee: University of Utah Research Foundation
    Inventors: Jean-Marc Lalouel, Xavier Jeunemaitre, Richard P. Lifton, Florent Soubrier, Youri Kotelevtsev, Pierre Corvol
  • Methods to determine predisposition to hypertension and association of variant angiotensinogen gene and hypertension
    Patent number: 5374525
    Abstract: The association of molecular variants of the angiotensinogen gene with human hypertension is disclosed. The determination of this association enables the screening of persons to identify those who have a predisposition to high blood presure.
    Type: Grant
    Filed: September 30, 1992
    Date of Patent: December 20, 1994
    Assignees: University of Utah Research Foundation, Inserm
    Inventors: Jean-Marc Lalouel, Xavier Jeunemaitre, Richard P. Lifton, Florant Soubrier, Youri Kotelevtsev, Pierre Corval